Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder (IP2)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00845260|
Recruitment Status : Completed
First Posted : February 18, 2009
Last Update Posted : February 18, 2009
|Condition or disease||Intervention/treatment||Phase|
|Panic Disorder||Behavioral: Internet-based cognitive behavior therapy (CBT). Behavioral: Group CBT||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||113 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Internet- Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder in a Psychiatric Setting: A Randomized Equivalence Trial|
|Study Start Date :||December 2004|
|Actual Primary Completion Date :||December 2007|
|Actual Study Completion Date :||December 2007|
Experimental: Internet CBT
Internet-based cognitive behavior therapy (CBT).
Behavioral: Internet-based cognitive behavior therapy (CBT).
Self-help program and guidance by psychologist via e-mail during 10 weeks.
Experimental: Group CBT
Group cognitive behavior therapy (CBT).
Behavioral: Group CBT
Group cognitive behavior therapy (CBT) during 10 weeks.
- Panic Disorder Severity Scale (PDSS) [ Time Frame: Pre, post at 6-month follow-up ]
- Montgomery-Åsberg Depression Rating Scale (MADRS) Anxiety Sensitivity Index (ASI) Sheehan Disability Scale (SDS) [ Time Frame: Pre, post and 6-month follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00845260
|Karolinska Institutet, Department of Clinical Neuroscience, Section of psychiatry, Karolinska Hospital Solna R5|
|Stockholm, Sweden, 171 76|
|Principal Investigator:||Nils Lindefors, MD, PhD, professor||Karolinska Institutet|